Usage Pattern and Serum Level Measurement of Amikacin in the Internal Medicine Ward of the Largest Referral Hospital in the South of Iran: A Pharmacoepidemiological Study

Usage Pattern and Serum Level Measurement of Amikacin in the Internal Medicine Ward of the Largest Referral Hospital in the South of Iran: A Pharmacoepidemiological Study

Background: The inappropriate use of aminoglycosides has harmful effects such as the development of resistant pathogens and the incidence of nephrotoxicity and ototoxicity. Therefore, drug utilization evaluation of these drugs may improve their usage remarkably. The aim of this study was to assess t...

Full description

Bibliographic Details
Main Authors:	Soha Namazi, Mohammad Mahdi Sagheb, Mohammad Mahdi Hashempour, Arman Sadatsharifi
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2016-05-01
Series:	Iranian Journal of Medical Sciences
Subjects:	Guideline Amikacin Drug utilization review
Online Access:	http://ijms.sums.ac.ir/index.php/IJMS/article/view/706

Similar Items

Initial In Vivo Evaluation of a Novel Amikacin-Deoxycholate Hydrophobic Salt Delivers New Insights on Amikacin Partition in Blood and Tissues
by: Styliani Xiroudaki, et al.
Published: (2021-01-01)

The Role of Aspirin as Otoprotective Agent in Patients Receiving Amikacin Therapy
by: Estabraq M. Mahdi
Published: (2011-06-01)

Clinical Pharmacokinetics of Amikacin in Neonates
by: Gian Maria Pacifici, et al.
Published: (2017-02-01)

Comparative Study between Combined Intravenous and Nebulized Amikacin versus Intravenous Amikacin Alone for Treatment of Ventilator Associated Pneumonia
by: Sameh Seyam, et al.
Published: (2022-06-01)

Intrathecal use of amikacin: a case report
by: L. Barrou, et al.

Validation of criteria for nosocomial use of amikacin in Brazil with the Delphi technique
by: L. Noblat, et al.

Protective effect of creatine on amikacin-induced ototoxicity
by: Emre Apaydın, et al.
Published: (2022-09-01)

The Direction of the Antibacterial Effect of Rutin Hydrate and Amikacin
by: Maria Miklasińska-Majdanik, et al.
Published: (2023-09-01)

Effect of mannitol on the pharmacokinetics of amikacin in wistar rats
by: Hugo Juárez Olguín, et al.
Published: (2009-08-01)

Intraperitoneal Amikacine Provoked Perceptive Deafness in CAPD - Continuous Ambulatory Peritoneal Dialysis Patient
by: Lutfi Zylbeari, et al.
Published: (2020-07-01)

Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin
by: Jonás Samuel Pérez-Blanco, et al.
Published: (2021-02-01)

Review on Population Pharmacokinetics of Amikacin in Paediatrics
by: Keerthana Chandrasekar, et al.
Published: (2022-12-01)

Protective Effect of Pentoxifylline on Amikacin-Induced Renal Toxicity in Mice
by: Mohammad Shokati Sayad, et al.
Published: (2023-10-01)

The Involvement of Drug Efflux System in Amikacin Resistance of Multiple Drug Resistant Acintobacter baumannii Isolates in Isfahan, Iran
by: Yalda Ostadi, et al.
Published: (2019-02-01)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
by: Zhang Z, et al.
Published: (2022-04-01)

Standard Multiple and Single Daily Dosing of Amikacin in Premature Infants
by: Arash Bordbar, et al.
Published: (2017-12-01)

Effect of sub MIC for Imipenem, Amikacin and Cefixime on Growth and Swarming of Proteus mirabilis
by: Hayder Hamzah Ibrahim, et al.
Published: (2018-12-01)

Amikacin: Uses, Resistance, and Prospects for Inhibition
by: Maria S. Ramirez, et al.
Published: (2017-12-01)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
by: Feiyang Zhang, et al.
Published: (2021-12-01)

Effects of atorvastatin on biomarkers of acute kidney injury in amikacin recipients: A pilot, randomized, placebo-controlled, clinical trial
by: Behrooz Heydari, et al.
Published: (2017-01-01)

Efficacy of intraventricular amikacin treatment in pan-resistant Pseudomonas aeruginosa postsurgical meningitis
by: Molinaro M, et al.
Published: (2018-09-01)

Effect of amikacin, cephalothin, clindamycin and vancomycin on in vitro fibroblast growth
by: Fernanda Timm Seabra Souza, et al.
Published: (2004-01-01)

Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
by: Maria Aquino, et al.
Published: (2023-02-01)

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence
by: Joy E. Gibson, et al.
Published: (2024-02-01)

The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection
by: Mohsen Yazdanian, et al.
Published: (2023-03-01)

Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy
by: Bonifasius Siyuka Singu, et al.
Published: (2023-01-01)

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada
by: Maria Luisa Aznar, et al.
Published: (2019-06-01)

The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection
by: Yuhang Wang, et al.
Published: (2022-10-01)

Study of the antimicrobial effect of Amikacin encapsulated in Mesoporous Silica nanoparticles against Pseudomonas aeruginosa and Staphylococcus aureus
by: Somayeh Hosseini khomeirani, et al.
Published: (2017-04-01)

Amikacin resistance due to the aphA6 gene in multi-antibiotic resistant Acinetobacter baumannii isolates belonging to global clone 1 from Iran
by: Parisa Aris, et al.
Published: (2019-09-01)

Analysis of Phenotypic and Genotypic Susceptibility to Clarithromycin and Amikacin of <i>Mycobacterium abscessus</i> Complex Strains Isolated from Cystic Fibrosis Patients
by: Juan Carlos Cao Yao, et al.
Published: (2023-11-01)

Amikacin Suppresses Human Breast Cancer Cell MDA-MB-231 Migration and Invasion
by: Yun-Hsin Wang, et al.
Published: (2020-11-01)

Enhanced effect of Amikacin in conjugation with gold nanopartcles as a carrier to kill Pseudomonas aeruginosa
by: Afsaneh Emameian, et al.
Published: (2020-12-01)

A Diet with Amikacin Changes the Bacteriobiome and the Physiological State of <i>Galleria mellonella</i> and Causes Its Resistance to <i>Bacillus thuringiensis</i>
by: Olga V. Polenogova, et al.
Published: (2023-11-01)

Evaluation of the Protective Effect of Beta Glucan on Amikacin Ototoxicity Using Distortion Product Otoacoustic Emission Measurements in Rats
by: Tuba Bayindir, et al.
Published: (2013-03-01)

Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
by: Timothy Aksamit, et al.
Published: (2022-12-01)

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach
by: Anne Coste, et al.
Published: (2023-01-01)

Assessment of Amikacin- and Capreomycin-Related Adverse Drug Reactions in Patients with Multidrug-Resistant Tuberculosis and Exploring the Role of Genetic Factors
by: Lauma Freimane, et al.
Published: (2023-03-01)

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
by: Xuanyou Jin, et al.
Published: (2020-11-01)

Profil Farmakokinetik Amikasin Pemberian Intravena Melalui Vena Sublingualis dan Coccygea pada Ular Sanca Batik (PHARMACOKINETIC PROFILE OF AMIKACIN ADMINISTERED INTRA VENOUSLY VIA SUBLINGUAL AND COCCYGEA VEINS IN BROGHAMMERUS RETICULATUS)
by: Agustina Dwi Wijayanti, et al.
Published: (2014-05-01)